{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:56:32Z","timestamp":1790744192015,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T00:00:00Z","timestamp":1694822400000},"content-version":"am","delay-in-days":350,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.jhep.2022.05.018","type":"journal-article","created":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T11:32:24Z","timestamp":1653651144000},"page":"1038-1046","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Bi-allelic hydroxymethylbilane synthase inactivation defines a homogenous clinico-molecular subtype of hepatocellular carcinoma"],"prefix":"10.1016","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3750-6561","authenticated-orcid":false,"given":"Laura","family":"Molina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0475-3934","authenticated-orcid":false,"given":"Eric","family":"Tr\u00e9po","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quentin","family":"Bayard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliana","family":"Amaddeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Le Bail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Chiche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulette","family":"Bioulac-Sage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Balabaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Possenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Decraecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Paradis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Laurent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fr\u00e9d\u00e9ric","family":"Blanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Calderaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Zucman-Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6369-2839","authenticated-orcid":false,"given":"Eric","family":"Letouz\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2022.05.018_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jhep.2022.05.018_bib2","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1053\/j.gastro.2016.11.042","article-title":"Molecular classification of hepatocellular adenoma associates with risk factors, bleeding, and malignant transformation","volume":"152","author":"Nault","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2022.05.018_bib3","doi-asserted-by":"crossref","first-page":"5235","DOI":"10.1038\/s41467-018-07552-9","article-title":"Cyclin A2\/E1 activation defines a hepatocellular carcinoma subclass with a rearrangement signature of replication stress","volume":"9","author":"Bayard","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2022.05.018_bib4","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/ng.3252","article-title":"Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets","volume":"47","author":"Schulze","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2022.05.018_bib5","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/ng.3547","article-title":"Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer","volume":"48","author":"Fujimoto","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2022.05.018_bib6","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.cell.2017.05.046","article-title":"Comprehensive and integrative genomic characterization of hepatocellular carcinoma","volume":"169","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2022.05.018_bib7","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1053\/j.gastro.2015.05.061","article-title":"Genetic landscape and biomarkers of hepatocellular carcinoma","volume":"149","author":"Zucman-Rossi","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2022.05.018_bib8","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature12912","article-title":"Discovery and saturation analysis of cancer genes across 21 tumour types","volume":"505","author":"Lawrence","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2022.05.018_bib9","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1046\/j.1365-2796.1996.21847000.x","article-title":"The epidemiology of hepatocellular carcinoma in patients with acute intermittent porphyria","volume":"240","author":"Andersson","year":"1996","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.jhep.2022.05.018_bib10","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1093\/oxfordjournals.aje.a009745","article-title":"Primary liver cancer, other malignancies, and mortality risks following porphyria: a cohort study in Denmark and Sweden","volume":"149","author":"Linet","year":"1999","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jhep.2022.05.018_bib11","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0168-8278(00)80097-5","article-title":"Hepatocellular carcinoma in patients with acute hepatic porphyria: frequency of occurrence and related factors","volume":"32","author":"Andant","year":"2000","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2022.05.018_bib12","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1365-2796.2010.02335.x","article-title":"Screening for hepatocellular carcinoma in acute intermittent porphyria: a 15-year follow-up in northern Sweden","volume":"269","author":"Innala","year":"2011","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.jhep.2022.05.018_bib13","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s10545-012-9576-9","article-title":"High risk of primary liver cancer in a cohort of 179 patients with Acute Hepatic Porphyria","volume":"36","author":"Sardh","year":"2013","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.jhep.2022.05.018_bib14","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ymgme.2018.10.001","article-title":"Hepatocellular carcinoma in acute hepatic porphyrias: a Damocles Sword","volume":"128","author":"Peoc\u2019h","year":"2019","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.jhep.2022.05.018_bib15","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1002\/hep.31460","article-title":"Hepatocellular carcinoma in acute hepatic porphyrias: results from the longitudinal study of the U.S. Porphyrias Consortium","volume":"73","author":"Saberi","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2022.05.018_bib16","doi-asserted-by":"crossref","unstructured":"Meyer UA, Strand LJ, Doss M, Rees AC, Marver HS. Intermittent acute porphyria \u2014 demonstration of a genetic defect in porphobilinogen metabolism. Https:\/\/Doi-OrgProxyInsermbiblioInistFr\/101056\/NEJM197206152862401 2010. https:\/\/doi.org\/10.1056\/NEJM197206152862401.","DOI":"10.1056\/NEJM197206152862401"},{"key":"10.1016\/j.jhep.2022.05.018_bib17","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0140-6736(09)61925-5","article-title":"Porphyrias","volume":"375","author":"Puy","year":"2010","journal-title":"The Lancet"},{"key":"10.1016\/j.jhep.2022.05.018_bib18","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/bjh.14459","article-title":"Update review of the acute porphyrias","volume":"176","author":"Stein","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jhep.2022.05.018_bib19","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1046\/j.1365-2796.1997.00189.x","article-title":"Acute intermittent porphyria: prevalence of mutations in the porphobilinogen deaminase gene in blood donors in France","volume":"242","author":"Nordmann","year":"1997","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.jhep.2022.05.018_bib20","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/humu.23067","article-title":"Acute intermittent porphyria: predicted pathogenicity of HMBS variants indicates extremely low penetrance of the autosomal dominant disease","volume":"37","author":"Chen","year":"2016","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jhep.2022.05.018_bib21","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ymgme.2019.03.002","article-title":"Pathogenesis and clinical features of the acute hepatic porphyrias (AHPs)","volume":"128","author":"Bonkovsky","year":"2019","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.jhep.2022.05.018_bib22","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1373\/clinchem.2005.058198","article-title":"Variations in porphobilinogen and 5-aminolevulinic acid concentrations in plasma and urine from asymptomatic carriers of the acute intermittent porphyria gene with increased porphyrin precursor excretion","volume":"52","author":"Floderus","year":"2006","journal-title":"Clin Chem"},{"key":"10.1016\/j.jhep.2022.05.018_bib23","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ejim.2008.06.012","article-title":"Plasma porphobilinogen as a sensitive biomarker to monitor the clinical and therapeutic course of acute intermittent porphyria attacks","volume":"20","author":"Sardh","year":"2009","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jhep.2022.05.018_bib24","doi-asserted-by":"crossref","DOI":"10.1111\/joim.13463","article-title":"Risk of primary liver cancer in acute hepatic porphyria patients: a matched cohort study of 1244 individuals","author":"Lissing","year":"2022","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.jhep.2022.05.018_bib25","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/bjc.1988.23","article-title":"Acute hepatic porphyria and hepatocellular carcinoma","volume":"57","author":"Kauppinen","year":"1988","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jhep.2022.05.018_bib26","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.jhep.2014.11.029","article-title":"Biallelic inactivation of protoporphyrinogen oxidase and hydroxymethylbilane synthase is associated with liver cancer in acute porphyrias","volume":"62","author":"Schneider-Yin","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2022.05.018_bib27","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature12213","article-title":"Mutational heterogeneity in cancer and the search for new cancer-associated genes","volume":"499","author":"Lawrence","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2022.05.018_bib28","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s00439-020-02199-3","article-title":"The Human Gene Mutation Database (HGMD\u00ae): optimizing its use in a clinical diagnostic or research setting","volume":"139","author":"Stenson","year":"2020","journal-title":"Hum Genet"},{"key":"10.1016\/j.jhep.2022.05.018_bib29","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/hep.31796","article-title":"DNA methylation signatures reveal the diversity of processes remodeling hepatocellular carcinoma methylomes","volume":"74","author":"Meunier","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2022.05.018_bib30","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1158\/2159-8290.CD-19-0074","article-title":"\u03b2-Catenin activation promotes immune escape and resistance to anti-PD-1 therapy in hepatocellular carcinoma","volume":"9","author":"Ruiz de Galarreta","year":"2019","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jhep.2022.05.018_bib31","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1093\/hmg\/ddy030","article-title":"From a dominant to an oligogenic model of inheritance with environmental modifiers in acute intermittent porphyria","volume":"27","author":"Lenglet","year":"2018","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jhep.2022.05.018_bib32","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1055\/s-2007-1007139","article-title":"Acute porphyrias: pathogenesis of neurological manifestations","volume":"18","author":"Meyer","year":"1998","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2022.05.018_bib33","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41420-019-0157-7","article-title":"Protoporphyrin IX is a dual inhibitor of p53\/MDM2 and p53\/MDM4 interactions and induces apoptosis in B-cell chronic lymphocytic leukemia cells","volume":"5","author":"Jiang","year":"2019","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.jhep.2022.05.018_bib34","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1074\/jbc.M608906200","article-title":"Protoporphyrin IX interacts with wild-type p53 protein in\u00a0vitro and induces cell death of human colon cancer cells in a p53-dependent and -independent manner","volume":"282","author":"Zawacka-Pankau","year":"2007","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jhep.2022.05.018_bib35","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.3389\/fonc.2019.01540","article-title":"The multifaceted role of heme in cancer","volume":"9","author":"Fiorito","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.jhep.2022.05.018_bib36","doi-asserted-by":"crossref","first-page":"851","DOI":"10.7326\/0003-4819-83-6-851","article-title":"Acute intermittent porphyria: clinical and selected research aspects","volume":"83","author":"Tschudy","year":"1975","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2022.05.018_bib37","first-page":"10","article-title":"LHRH analogues for hormonal manipulation in acute intermittent porphyria","volume":"26","author":"Anderson","year":"1989","journal-title":"Semin Hematol"},{"key":"10.1016\/j.jhep.2022.05.018_bib38","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0021-9258(18)96783-9","article-title":"The induction in\u00a0vitro of the synthesis of delta-aminolevulinic acid synthetase in chemical porphyria: a response to certain drugs, sex hormones, and foreign chemicals","volume":"241","author":"Granick","year":"1966","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jhep.2022.05.018_bib39","doi-asserted-by":"crossref","unstructured":"Anderson KE, Spitz IM, Sassa S, Bardin CW, Kappas A. Prevention of cyclical attacks of acute intermittent porphyria with a long-acting agonist of luteinizing hormone\u2013releasing hormone. Http:\/\/DxDoiOrg\/101056\/NEJM198409063111006 2010. https:\/\/doi.org\/10.1056\/NEJM198409063111006.","DOI":"10.1056\/NEJM198409063111006"},{"key":"10.1016\/j.jhep.2022.05.018_bib40","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jhep.2018.09.023","article-title":"Loss of hepatocyte \u03b2-catenin protects mice from experimental porphyria-associated liver injury","volume":"70","author":"Saggi","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2022.05.018_bib41","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1515\/bc.2010.115","article-title":"Zonation of heme synthesis enzymes in mouse liver and their regulation by \u03b2-catenin and Ha-ras","volume":"391","author":"Braeuning","year":"2010","journal-title":"Biol Chem"},{"key":"10.1016\/j.jhep.2022.05.018_bib42","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2022.05.018_bib43","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","article-title":"The emerging hallmarks of cancer metabolism","volume":"23","author":"Pavlova","year":"2016","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhep.2022.05.018_bib44","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1126\/science.1164382","article-title":"An integrated genomic analysis of human glioblastoma multiforme","volume":"321","author":"Parsons","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.jhep.2022.05.018_bib45","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJMoa0903840","article-title":"Recurring mutations found by sequencing an acute myeloid leukemia genome","volume":"361","author":"Mardis","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhep.2022.05.018_bib46","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1126\/science.287.5454.848","article-title":"Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma","volume":"287","author":"Baysal","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.jhep.2022.05.018_bib47","first-page":"4554","article-title":"Few FH mutations in sporadic counterparts of tumor types observed in hereditary leiomyomatosis and renal cell cancer families","volume":"62","author":"Kiuru","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhep.2022.05.018_bib48","doi-asserted-by":"crossref","first-page":"956","DOI":"10.15252\/msb.20177739","article-title":"An integrated computational and experimental study uncovers FUT9 as a metabolic driver of colorectal cancer","volume":"13","author":"Auslander","year":"2017","journal-title":"Mol Syst Biol"},{"key":"10.1016\/j.jhep.2022.05.018_bib49","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/s41467-017-01358-x","article-title":"Mutational signatures reveal the dynamic interplay of risk factors and cellular processes during liver tumorigenesis","volume":"8","author":"Letouz\u00e9","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2022.05.018_bib50","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.jhep.2019.12.006","article-title":"BAP1 mutations define a homogeneous subgroup of hepatocellular carcinoma with fibrolamellar-like features and activated PKA","volume":"72","author":"Hirsch","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2022.05.018_bib51","article-title":"Hepatitis B virus integrations promote local and distant oncogenic driver alterations in hepatocellular carcinoma","author":"P\u00e9neau","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2022.05.018_bib52","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/hep.29762","article-title":"Macrotrabecular-massive hepatocellular carcinoma: a distinctive histological subtype with clinical relevance","volume":"68","author":"Ziol","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2022.05.018_bib53","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1093\/bioinformatics\/bty388","article-title":"Palimpsest: an R package for studying mutational and structural variant signatures along clonal evolution in cancer","volume":"34","author":"Shinde","year":"2018","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jhep.2022.05.018_bib54","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1124\/dmd.116.070920","article-title":"A\u00a0high dose of isoniazid disturbs endobiotic homeostasis in mouse liver","volume":"44","author":"Li","year":"2016","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jhep.2022.05.018_bib55","doi-asserted-by":"crossref","first-page":"eaaw6127","DOI":"10.1126\/sciadv.aaw6127","article-title":"The essential role of the transporter ABCG2 in the pathophysiology of erythropoietic protoporphyria","volume":"5","author":"Wang","year":"2019","journal-title":"Sci Adv"},{"key":"10.1016\/j.jhep.2022.05.018_bib56","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1021\/acs.chemrestox.8b00023","article-title":"Identification of novel pathways in idelalisib metabolism and bioactivation","volume":"31","author":"Zhu","year":"2018","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.jhep.2022.05.018_bib57","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/hep.21467","article-title":"Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets","volume":"45","author":"Boyault","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2022.05.018_bib58","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/hep.30811","article-title":"Clinical impact of genomic diversity from early to advanced hepatocellular carcinoma","volume":"71","author":"Nault","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2022.05.018_bib59","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1053\/j.gastro.2019.05.001","article-title":"Analysis of liver cancer cell lines identifies agents with likely efficacy against hepatocellular carcinoma and markers of response","volume":"157","author":"Caruso","year":"2019","journal-title":"Gastroenterology"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827822003336?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827822003336?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:47:31Z","timestamp":1759175251000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827822003336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S0168827822003336"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2022.05.018","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bi-allelic hydroxymethylbilane synthase inactivation defines a homogenous clinico-molecular subtype of hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2022.05.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}